These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38741470)

  • 21. Detecting aspartate isomerization and backbone cleavage after aspartate in intact proteins by NMR spectroscopy.
    Hinterholzer A; Stanojlovic V; Regl C; Huber CG; Cabrele C; Schubert M
    J Biomol NMR; 2021 Jan; 75(1):71-82. PubMed ID: 33475951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unusual fragmentation of β-linked peptides by ExD tandem mass spectrometry.
    Sargaeva NP; Lin C; O'Connor PB
    J Am Soc Mass Spectrom; 2011 Mar; 22(3):480-91. PubMed ID: 21472566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.
    Sreedhara A; Cordoba A; Zhu Q; Kwong J; Liu J
    Pharm Res; 2012 Jan; 29(1):187-97. PubMed ID: 21809161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein isoaspartate methyltransferase-mediated 18O-labeling of isoaspartic acid for mass spectrometry analysis.
    Liu M; Cheetham J; Cauchon N; Ostovic J; Ni W; Ren D; Zhou ZS
    Anal Chem; 2012 Jan; 84(2):1056-62. PubMed ID: 22132761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Fluorescence-Based High-Throughput Coupled Enzymatic Assay for Quantitation of Isoaspartate in Proteins and Peptides.
    Puri A; Quan Y; Narang AS; Adams M; Gandhi R; Nashine VC
    AAPS PharmSciTech; 2017 Apr; 18(3):803-808. PubMed ID: 27342117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deuterium Labeling of Isoaspartic and Isoglutamic Acids for Mass Spectrometry Analysis.
    Miyagi M; Kiesel E; Neumbo K; Nakazawa T
    Anal Chem; 2024 Feb; 96(7):3077-3086. PubMed ID: 38344941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ion-pair reversed-phase high performance liquid chromatography method for the quantification of isoaspartic acid in a monoclonal antibody.
    Kern W; Mende R; Denefeld B; Sackewitz M; Chelius D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 955-956():26-33. PubMed ID: 24631807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.
    Kuang J; Tao Y; Song Y; Chemmalil L; Mussa N; Ding J; Li ZJ
    Anal Bioanal Chem; 2021 Mar; 413(8):2113-2123. PubMed ID: 33543314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass spectrometric differentiation of alpha- and beta-aspartic acid in a pseudo-tetrapeptide thrombosis inhibitor and its isomer.
    Luu NC; Robinson S; Zhao R; McKean R; Ridge DP
    Eur J Mass Spectrom (Chichester); 2004; 10(2):279-87. PubMed ID: 15103105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electron transfer dissociation with supplemental activation to differentiate aspartic and isoaspartic residues in doubly charged peptide cations.
    Chan WY; Chan TW; O'Connor PB
    J Am Soc Mass Spectrom; 2010 Jun; 21(6):1012-5. PubMed ID: 20304674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of degradation products of aspartyl tripeptides by capillary electrophoresis-tandem mass spectrometry.
    De Boni S; Neusüss C; Pelzing M; Scriba GK
    Electrophoresis; 2003 Mar; 24(5):874-82. PubMed ID: 12627450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragmentation of the deprotonated ions of peptides containing cysteine, cysteine sulfinic acid, cysteine sulfonic acid, aspartic acid, and glutamic acid.
    Men L; Wang Y
    Rapid Commun Mass Spectrom; 2006; 20(5):777-84. PubMed ID: 16470564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinguishing Aspartic and Isoaspartic Acids in Peptides by Several Mass Spectrometric Fragmentation Methods.
    DeGraan-Weber N; Zhang J; Reilly JP
    J Am Soc Mass Spectrom; 2016 Dec; 27(12):2041-2053. PubMed ID: 27613306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of the isomerization of Asp residue in recombinant human alpha A-crystallin by reversed-phase HPLC.
    Sadakane Y; Yamazaki T; Nakagomi K; Akizawa T; Fujii N; Tanimura T; Kaneda M; Hatanaka Y
    J Pharm Biomed Anal; 2003 Jan; 30(6):1825-33. PubMed ID: 12485724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5.
    Liu S; Moulton KR; Auclair JR; Zhou ZS
    Amino Acids; 2016 Apr; 48(4):1059-1067. PubMed ID: 26748652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Resolution Demultiplexing (HRdm) Ion Mobility Spectrometry-Mass Spectrometry for Aspartic and Isoaspartic Acid Determination and Screening.
    Butler KE; Dodds JN; Flick T; Campuzano IDG; Baker ES
    Anal Chem; 2022 Apr; 94(16):6191-6199. PubMed ID: 35421308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The amino terminus of PKA catalytic subunit--a site for introduction of posttranslational heterogeneities by deamidation: D-Asp2 and D-isoAsp2 containing isozymes.
    Kinzel V; König N; Pipkorn R; Bossemeyer D; Lehmann WD
    Protein Sci; 2000 Nov; 9(11):2269-77. PubMed ID: 11152138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A DFT calculation on nonenzymatic degradation of isoaspartic residue.
    Sang-Aroon W; Phatchana R; Tontapha S; Ruangpornvisuti V
    J Mol Model; 2021 Sep; 27(10):300. PubMed ID: 34570254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cleavage of isoaspartyl peptide bonds by hydroxylamine after methyltransferase priming.
    Zhu JX; Aswad DW
    Anal Biochem; 2007 May; 364(1):1-7. PubMed ID: 17376395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient Conformations Leading to Peptide Fragment Ion [c + 2H]
    Takayama M
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.